Verona Pharma (NASDAQ:VRNA) Sets New 52-Week High Following Analyst Upgrade
Verona Pharma plc (NASDAQ:VRNA – Get Free Report) shares reached a new 52-week high on Monday after HC Wainwright raised their price target on the stock from $85.00 to $90.00. HC Wainwright currently has a buy rating on the stock. Verona Pharma traded as high as $83.41 and last traded at $82.46, with a volume […]
Verona Pharma plc (NASDAQ:VRNA – Get Free Report) shares reached a new 52-week high on Monday after HC Wainwright raised their price target on the stock from $85.00 to $90.00. HC Wainwright currently has a buy rating on the stock. Verona Pharma traded as high as $83.41 and last traded at $82.46, with a volume […]
